Professor of Surgery
General Surgery
Dr. Joshua D. Ellenhorn, MD
|
|
Give Review
Joshua Ellenhorn practices General Surgery. He graduated from Boston University School of Medicine. Boston University School of Medicine is ranked 30/52 in Research/PrimaryCare. He has 22 awards "America's Top Doctors", "Top Doctors:LA Area", "America's Top Doctors for Cancer", "Top Doctors:Southern California", "US News and World Report Top 1% of Surgeons in United States", "Top 1% of Surgeons in United States", "Pasadena Magazine Top Doctors", "Top Doctors", "Listed in America's Top Doctors for Cancer, 1st", "Listed in America's Top Doctors for Cancer, 1st 6th editions", "Young Surgeon Representative from the Southern California Chapter to the American College of Surgeons", "Young Surgeon Representative from the Southern California Chapter", "New York Society of Colon and Rectal Surgeons", "First Place in the Residents Research Presentation", "American Cancer Society Clinical Oncology Fellowship Award", "Clinical Oncology Fellowship Award", "American College of Surgeons", "First Place in the Ohio State Chapter Resident Essay Contest", "NIH Post-Doctoral Fellowship in Endocrinology", "Fight for Sight Student Research Fellowship", "Fellow (FACS)" and "Super Doctor". Joshua Ellenhorn is a published doctor. He published 78 publications, including: 'Targeting p53 for adoptive T-cell immunotherapy.' Joshua Ellenhorn accepts Medicare payments and is listed with Medicare.gov.
Publications
- Evaluation of expert criteria for preoperative magnetic resonance imaging of newly diagnosed breast Cancer.
- Adipose Stromal Vascular Fraction Isolation: A Head-to-Head Comparison of Four Commercial Cell Separation Systems.
- When it comes to the efficacy of metastasectomy, biology is king.
- Salvage abdominoperineal resection following combined chemotherapy and radiotherapy for epidermoid carcinoma of the anus.
- Impact of therapeutic regional lymph node dissection for medullary carcinoma of the Thyroid gland.
- CEA for monitoring colon Cancer.
- Exposure of the mucosa of the gastroEsophageal junction in patients with Mallory-Weiss tears.
- Treatment-related esophageal stricture in pediatric patients with Cancer.
- Survey of physicians' attitudes relative to the field of surgical oncology.
- Treatment of periAnal infection following bone marrow transplantation.
- Local recurrence in breast Cancer: implications for systemic disease.
- The use of transgenic mice to generate high affinity p53 specific cytolytic T cells.
- Surgical management of thyroid Cancer invading the airway.
- An HLA-restricted, p53 specific immune response from HLA transgenic p53 knockout mice.
- Targeting p53 for adoptive T-cell immunotherapy.
- Influence of hospital volume on mortality following major Cancer surgery.
- Beyond palliative mastectomy in inflammatory breast Cancer--a reassessment of margin status.
- An orthotopic in vivo model of human pancreatic Cancer.
- A mortality-free decade of pancreatoduodenectomy: is quality independent of quantity?
- Immunotherapy of bladder Cancer targeting P53.
- Targeting of human p53-overexpressing tumor cells by an HLA A*0201-restricted murine T-cell receptor expressed in Jurkat T cells.
- Esthetic reconstruction after mastectomy for inflammatory breast Cancer: is it worthwhile?
- TransAnal excision for low rectal cancers is curative in early-stage disease with favorable histology.
- Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast Cancer.
- Asymptomatic renal neoplasms in the Rectal cancer patient.
- Intraoperative radiation therapy for patients with recurrent Rectal and sigmoid colon cancer in previously irradiated fields.
- A functional recombinant single-chain T cell receptor fragment capable of selectively targeting antigen-presenting cells.
- CTLA-4 blockade enhances the therapeutic effect of an attenuated poxvirus vaccine targeting p53 in an established murine tumor model.
- Microsatellite instability is a rare finding in tumors of patients with both primary renal and Rectal neoplasms.
- Attenuated poxviruses generate clinically relevant frequencies of CMV-specific T cells.
- DNA fingerprinting and breast Cancer.
- Two distinct pathways of immuno-modulation improve potency of p53 immunization in rejecting established Tumors.
- Paint-only is equivalent to scrub-and-paint in preoperative preparation of abdominal surgery sites.
- Radioactive iodine offers survival improvement in patients with follicular carcinoma of the Thyroid.
- Full-thickness chest wall resection for recurrent breast carcinoma: an institutional review and meta-Analysis.
- The implication of lymph node metastasis on survival in patients with well-differentiated thyroid Cancer.
- Robotic-assisted laparoscopic low anterior resection with total mesoRectal excision for Rectal cancer.
- Factors affecting survival in patients with Anal melanoma.
- An MVA vaccine overcomes tolerance to human p53 in mice and humans.
- Increased abdominal girth in a 29-year-old breast Cancer patient with extensive liver metastasis and presumed chemotherapy induced amenorrhea. A case report and review...
- Survival in patients with papillary thyroid Cancer is not affected by the use of radioactive isotope.
- Impact of a full-time preceptor on the institutional outcome of laparoscopic colectomy.
- Short-term outcomes after robotic-assisted total mesoRectal excision for Rectal cancer.
- The role of positron emission tomography scanning in patients with radioactive iodine scan-negative, recurrent differentiated thyroid Cancer.
- The impact of lymph node number on survival in patients with lymph node-negative pancreatic Cancer.
- Metastatic gastrointestinal stromal Tumors in the era of imatinib: improved survival and elimination of socioeconomic survival disparities.
- Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the Skin.
- The anatomic location of pancreatic Cancer is a prognostic factor for survival.
- Totally laparoscopic gastric resection with extended lymphadenectomy for gastric adenocarcinoma.
- Race and ethnicity correlate with survival in patients with gastric adenocarcinoma.
- CC chemokine receptor 9 enhances proliferation in pancreatic intraepithelial neoplasia and pancreatic Cancer cells.
- The incidence and outcomes of pancreatectomy in patients with metastatic Pancreatic adenocarcinoma.
- Minimally invasive total gastrectomy for gastric Cancer: a pilot series.
- Modified vaccinia Ankara expressing survivin combined with gemcitabine generates specific antitumor effects in a murine Pancreatic carcinoma model.
- Heterologous prime/boost immunization with p53-based vaccines combined with toll-like receptor stimulation enhances tumor regression.
- Neoadjuvant therapy is associated with improved survival in resectable Pancreatic adenocarcinoma.
- Enhancement of Cancer vaccine therapy by systemic delivery of a tumor-targeting Salmonella-based STAT3 shRNA suppresses the growth of established melanoma tumors.
- Recombinant modified vaccinia virus ankara (MVA) expressing wild-type human p53 induces specific antitumor CTL expansion.
- Selection criteria for complete cytoreduction after cytoreductive surgery for peritoneal surface malignancy: lessons learned from our first series of patients.
- Disparities in reconstruction rates after mastectomy: patterns of care and factors associated with the use of Breast reconstruction in Southern California.
- Surgical resection and multidisciplinary care for primary and metastatic Pancreatic islet cell carcinomas.
- Human papillomavirus infection as a prognostic factor in oropharyngeal squamous cell carcinomas treated in a prospective phase II clinical trial.
- Adjuvant radiation therapy is associated with improved survival for gallBladder carcinoma with regional metastatic disease.
- Skin-sparing mastectomy: a survey based approach to defining standard of care.
- Pilot series of robot-assisted laparoscopic subtotal gastrectomy with extended lymphadenectomy for gastric Cancer.
- NCCN Practice Guidelines for Head and Neck Cancers.
- Robotic surgery for gastrointestinal Malignancies.
- Clinical and functional properties of novel VHL mutation (X214L) consistent with Type 2A phenotype and low risk of renal cell carcinoma.
- Immunopotentiation of anti-viral and anti-tumor immune responses using anti-T cell receptor antibodies and mitogens.
- In vivo T-cell activation by staphylococcal enterotoxin B prevents outgrowth of a malignant tumor.
- Mechanism of tumor rejection in anti-CD3 monoclonal antibody-treated mice.
- Activation of human T cells in vivo following treatment of transplant recipients with OKT3.
- Treatment with monoclonal anti-CD3 antibody protects against lethal Sendai virus infection by induction of natural killer cells.
- T lymphocyte activation following OKT3 treatment.
- Dose-dependent activation of murine T cells following in vivo administration of anti-murine CD3.
- In vivo administration of anti-CD3 prevents malignant progressor tumor growth.
- In vivo administration of anti-CD3 monoclonal antibody can activate immune responses thus preventing malignant tumor growth.
Schools
Boston University School Of Medicine
University Cincinnati
Procedures Preformed
- Lymph Node Biopsy or Excision
- Port Placements or Replacements
Conditions Treated
- Anal and Rectal Cancer
- Appendicitis
- Bladder Cancer
- Breast Cancer
- View All
Doctors Specialties
- Complex General Surgical Oncology
- General Surgery
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:LA Area
- America's Top Doctors for Cancer
- Top Doctors:Southern California
- US News and World Report – Top 1% of Surgeons in United States
- Top 1% of Surgeons in United States
- Pasadena Magazine Top Doctors
- Top Doctors
- Listed in America's Top Doctors for Cancer, 1st
- Listed in America's Top Doctors for Cancer, 1st – 6th editions
- Young Surgeon Representative from the Southern California Chapter to the American College of Surgeons
- Young Surgeon Representative from the Southern California Chapter
- New York Society of Colon and Rectal Sur¬geons
- First Place in the Residents Research Presentation
- American Cancer Society Clinical Oncology Fellowship Award
- Clinical Oncology Fellowship Award
- American College of Surgeons
- First Place in the Ohio State Chap¬ter Resident Essay Contest
- NIH Post-Doctoral Fellowship in Endocrinology
- Fight for Sight Student Research Fellowship
- Fellow (FACS)
- Super Doctor
Education
-
Memorial Sloan-Kettering Cancer Center -
University Hospital - University of Cincinnati College of Medicine -
University Hospital/University of Cincinnati College of Medicine -
University of Chicago -
Boston University -
Boston University School of Medicine
Hospital
-
Cedars-Sinai Medical Center -
Huntington Memorial Hospital
Drug Facts
| NPI NUMBER | 1699871525 | |
| NPPES Provider LastName | ELLENHORN | |
| NPPES Provider FirstName | JOSHUA | |
| NPPES Provider ZIPCode | 900485901 | |
| NPPES Provider State | CA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 18.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1699871525 |
| Last Name Of The Provider | ELLENHORN |
| First Name Of The Provider | JOSHUA |
| View All |
Similar Doctors
|
Dr. Matthew A. Lublin, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Gregory M. Senofsky, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Suzanne A. Trott, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Maggie L. Dinome, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Henry K. Kawamoto Jr., MD |
|
Dr. Travis B. Kidner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donald L. Morton, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Francis Brunicardi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yelena Badalova, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael J. Seibert, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Connie G. Chiu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan M. Love, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Matthew J. Thompson, PA-C
This Doctor is OpenDoctor Recommended.
|